BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33241681)

  • 1. A Glycosylated Prodrug to Attenuate Neuroinflammation and Improve Cognitive Deficits in Alzheimer's Disease Transgenic Mice.
    Kim M; Park MH; Nam G; Lee M; Kang J; Song IS; Choi MK; Jin HK; Bae JS; Lim MH
    Mol Pharm; 2021 Jan; 18(1):101-112. PubMed ID: 33241681
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Park MH; Lee M; Nam G; Kim M; Kang J; Choi BJ; Jeong MS; Park KH; Han WH; Tak E; Kim MS; Lee J; Lin Y; Lee YH; Song IS; Choi MK; Lee JY; Jin HK; Bae JS; Lim MH
    Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23426-23436. PubMed ID: 31685616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydroxy stilbene glycoside alleviated inflammatory damage by mitophagy via AMPK related PINK1/Parkin signaling pathway.
    Gao Y; Li J; Li J; Hu C; Zhang L; Yan J; Li L; Zhang L
    Biochem Pharmacol; 2020 Jul; 177():113997. PubMed ID: 32353422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease.
    Li HQ; Ip SP; Yuan QJ; Zheng GQ; Tsim KKW; Dong TTX; Lin G; Han Y; Liu Y; Xian YF; Lin ZX
    Brain Behav Immun; 2019 Nov; 82():264-278. PubMed ID: 31476414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OAB-14, a bexarotene derivative, improves Alzheimer's disease-related pathologies and cognitive impairments by increasing β-amyloid clearance in APP/PS1 mice.
    Yuan C; Guo X; Zhou Q; Du F; Jiang W; Zhou X; Liu P; Chi T; Ji X; Gao J; Chen C; Lang H; Xu J; Liu D; Yang Y; Qiu S; Tang X; Chen G; Zou L
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):161-180. PubMed ID: 30389579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Administration of Alpha Linoleic Acid Rescues Aβ-Induced Glia-Mediated Neuroinflammation and Cognitive Dysfunction in C57BL/6N Mice.
    Ali W; Ikram M; Park HY; Jo MG; Ullah R; Ahmad S; Abid NB; Kim MO
    Cells; 2020 Mar; 9(3):. PubMed ID: 32182943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
    Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
    Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous Administration of AMD3100 into Mice Models of Alzheimer's Disease Ameliorated Cognitive Impairment, Reduced Neuroinflammation, and Improved Pathophysiological Markers.
    Gavriel Y; Rabinovich-Nikitin I; Ezra A; Barbiro B; Solomon B
    J Alzheimers Dis; 2020; 78(2):653-671. PubMed ID: 33016905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide ribose ameliorates cognitive impairment of aged and Alzheimer's disease model mice.
    Xie X; Gao Y; Zeng M; Wang Y; Wei TF; Lu YB; Zhang WP
    Metab Brain Dis; 2019 Feb; 34(1):353-366. PubMed ID: 30523581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Heptadecylresorcinol, a Biomarker for Whole Grain Rye Consumption, Ameliorates Cognitive Impairments and Neuroinflammation in APP/PS1 Transgenic Mice.
    Liu J; Wang Y; Wang Z; Hao Y; Bai W; Wang Z; Wang J
    Mol Nutr Food Res; 2020 Jun; 64(11):e1901218. PubMed ID: 32385942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavonoid-rich ethanol extract from the leaves of Diospyros kaki attenuates cognitive deficits, amyloid-beta production, oxidative stress, and neuroinflammation in APP/PS1 transgenic mice.
    Ma Y; Ma B; Shang Y; Yin Q; Hong Y; Xu S; Shen C; Hou X; Liu X
    Brain Res; 2018 Jan; 1678():85-93. PubMed ID: 29038004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of tormentic acid against memory impairment and neuro‑inflammation in an Alzheimer's disease mouse model.
    Cui W; Sun C; Ma Y; Wang S; Wang X; Zhang Y
    Mol Med Rep; 2020 Aug; 22(2):739-750. PubMed ID: 32468017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
    Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
    Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin mitigates cognitive impairment and protects neurons from microglia-mediated neuroinflammation via suppressing NLRP3 inflammasomes and TLR4/NF-κB signaling pathway.
    Jin X; Liu MY; Zhang DF; Zhong X; Du K; Qian P; Yao WF; Gao H; Wei MJ
    CNS Neurosci Ther; 2019 May; 25(5):575-590. PubMed ID: 30676698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative evaluation of treatments with 17β-estradiol and its brain-selective prodrug in a double-transgenic mouse model of Alzheimer's disease.
    Tschiffely AE; Schuh RA; Prokai-Tatrai K; Prokai L; Ottinger MA
    Horm Behav; 2016 Jul; 83():39-44. PubMed ID: 27210479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bulbocodin D ameliorate cognitive impairment in APP/PS1 transgenic mice by modulating amyloid-beta burden, oxidative status and neuroinflammation.
    Hao F; Feng Y
    Psychopharmacology (Berl); 2021 Aug; 238(8):2073-2082. PubMed ID: 33811504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.